Angiopoietin-2: Modulator of Vascular Permeability in Acute Lung Injury?

Tomoki Hashimoto; Jean-Francois Pittet

doi:10.1371/journal.pmed.0030113

Loading metrics

Open Access

Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

Angiopoietin-2: Modulator of Vascular Permeability in Acute Lung Injury?

Tomoki Hashimoto,
Jean-Francois Pittet

*To whom correspondence should be addressed. E-mail: pittetj@anesthesia.ucsf.edu
⨯

Angiopoietin-2: Modulator of Vascular Permeability in Acute Lung Injury?

Tomoki Hashimoto,
Jean-Francois Pittet

Published: February 7, 2006
https://doi.org/10.1371/journal.pmed.0030113

About the Authors

Tomoki Hashimoto
Jean-Francois Pittet: *To whom correspondence should be addressed. E-mail: pittetj@anesthesia.ucsf.edu

Competing Interests

The authors declare that no competing interests exist.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Endothelial cells
Is the Subject Area "Endothelial cells" applicable to this article?

Thanks for your feedback.
Vascular permeability
Is the Subject Area "Vascular permeability" applicable to this article?

Thanks for your feedback.
Angiogenesis
Is the Subject Area "Angiogenesis" applicable to this article?

Thanks for your feedback.
Sepsis
Is the Subject Area "Sepsis" applicable to this article?

Thanks for your feedback.
Growth factors
Is the Subject Area "Growth factors" applicable to this article?

Thanks for your feedback.
Lungs
Is the Subject Area "Lungs" applicable to this article?

Thanks for your feedback.
VEGF signaling
Is the Subject Area "VEGF signaling" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.